In contrast to the broader process manufacturing sector, the life sciences industry is subject to a complex and evolutionary regulatory system that affects the way plant infrastructure must be procured and integrated. Further, adherence to GMPs and cGMPs requires the need for clean-room technologies, which must work seamlessly with the process infrastructure housed therein.